{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:47:09Z","timestamp":1790693229678,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.thromres.2014.12.020","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T06:45:21Z","timestamp":1420181121000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsis"],"prefix":"10.1016","volume":"135","author":[{"given":"Marcel","family":"Schouten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"van \u2018t Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Poulussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Esmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.12.020_bb0005","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Whitney CG; Infectious Diseases Society of America; American Thoracic Society: Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thromres.2014.12.020_bb0010","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/01.CCM.0000162381.24074.D7","article-title":"Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study","volume":"33","author":"Laterre","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.thromres.2014.12.020_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.thromres.2014.12.020_bb0020","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/01.CCM.0000057849.53689.65","article-title":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia","volume":"31","author":"Levi","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.thromres.2014.12.020_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1160\/TH07-11-0666","article-title":"Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstititial lung diseases","volume":"99","author":"Wygrecka","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-011-0284-6","article-title":"Protein C anticoagulant system \u2013 anti-inflammatory effects","volume":"34","author":"Esmon","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.12.020_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jth.12247","article-title":"Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway","volume":"11","author":"Bouwens","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0040","doi-asserted-by":"crossref","first-page":"L514","DOI":"10.1152\/ajplung.00442.2002","article-title":"Protein C and thrombomodulin in human acute lung injury","volume":"285","author":"Ware","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.thromres.2014.12.020_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thorax.2003.013888","article-title":"Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia","volume":"59","author":"Schultz","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.thromres.2014.12.020_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1378\/chest.120.3.915","article-title":"Low levels of protein C are associated with poor outcome in severe sepsis","volume":"120","author":"Yan","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.12.020_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1538-7836.2009.03333.x","article-title":"Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock","volume":"7","author":"Xu","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1538-7836.2010.04089.x","article-title":"Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia","volume":"9","author":"Van Den Boogaard","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0065","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/cc9213","article-title":"Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study","volume":"14","author":"Schouten","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.12.020_bb0070","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jir185","article-title":"Osteopontin impairs host defense during pneumococcal pneumonia","volume":"203","author":"Van der Windt","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.thromres.2014.12.020_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1661109","article-title":"Evidence for the Occurrence of A Fast-Acting Inhibitor for Tissue-Type Plasminogen-Activator in Human-Plasma","volume":"51","author":"Verheijen","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0038-1657277","article-title":"A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma","volume":"48","author":"Verheijen","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0085","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/cc9213","article-title":"Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study","volume":"14","author":"Schouten","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.12.020_bb0090","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood.V88.6.2093.bloodjournal8862093","article-title":"The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent","volume":"88","author":"Bajzar","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.12.020_bb0095","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0038-1647055","article-title":"Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor\u2013no evidence for a cofactor role of protein S","volume":"60","author":"De Fouw","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1165\/rcmb.2010-0370OC","article-title":"Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice","volume":"45","author":"Schouten","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.thromres.2014.12.020_bb0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jth.12094","article-title":"Endogenous protein C has a protective role during Gram-negative pneumosepsis (meliodosis)","volume":"11","author":"Kager","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0110","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2011.04199.x","article-title":"Endogenous protein C inhibits activation of coagulation and transiently lowers bacterial outgrowth in murine Escherichia coli peritonitis","volume":"5","author":"Schouten","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.020_bb0115","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20070404","article-title":"Endotoxemia and sepsis mortality reduction by non-anticoagulant-activated protein C","volume":"204","author":"Kerschen","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2014.12.020_bb0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1165\/rcmb.2010-0397OC","article-title":"Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice","volume":"45","author":"Bir","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.thromres.2014.12.020_bb0125","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1172\/JCI42629","article-title":"Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice","volume":"120","author":"Kerschen","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.12.020_bb0130","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1172\/JCI40380","article-title":"The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b","volume":"120","author":"Cao","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.12.020_bb0135","doi-asserted-by":"crossref","first-page":"R238","DOI":"10.1186\/cc11910","article-title":"Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study","volume":"16","author":"Schouten","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.12.020_bb0140","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/blood-2004-10-3985","article-title":"Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation","volume":"105","author":"Feistritzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.12.020_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1165\/rcmb.2006-0327OC","article-title":"Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation","volume":"37","author":"Singleton","year":"2007","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T14:55:26Z","timestamp":1598626526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814006896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0049384814006896"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.020","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}